Provided by Tiger Trade Technology Pte. Ltd.

Global X Aging Population ETF

36.93
-0.0850-0.23%
Post-market: 36.990.0650+0.18%19:56 EDT
Volume:5K
Turnover:183.64K
Market Cap:91.19M
PE:- -
High:37.08
Open:37.08
Low:36.83
Close:37.01
52wk High:39.48
52wk Low:32.44
Shares:2.47M
Float Shares:2.47M
Volume Ratio:0.39
T/O Rate:0.20%
Dividend:0.33
Dividend Rate:0.89%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Brain-Computer Interface Startups Must Walk the Line Between Vast Potential and Near-Term Medical Reality, Says Formatia Founder

Deep News
·
Sep 05

Healthpeak Properties Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 05

AcroMeta Moves Into Cell Therapy Logistics With Southeast Asia ATCLS Deal

TIPRANKS
·
Sep 05

Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch

TIPRANKS
·
Sep 05

Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbbVie (ABBV)

TIPRANKS
·
Sep 04

J.P. Morgan Remains a Buy on Ventas (VTR)

TIPRANKS
·
Sep 04

Scotiabank Remains a Buy on AbbVie (ABBV)

TIPRANKS
·
Sep 04

Guizhou-Based Firm Earns National Recognition for Veterans Support Efforts

Deep News
·
Sep 04

AbbVie Closes $10.9B Takeover of Apogee, Its Largest Deal Since 2019, With Earnings Lift Expected From 2032

Stock News
·
Sep 04

Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 04

Eli Lilly Stock (LLY) Gets a Bullish Note from JPMorgan Chase

TIPRANKS
·
Sep 04

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live
·
Sep 04

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 04

AbbVie's Phase 3 Study of Etentamig in Multiple Myeloma Meets Dual Primary Endpoints

MT Newswires Live
·
Sep 03

AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study

Dow Jones
·
Sep 03

AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS

TIPRANKS
·
Sep 03

AbbVie's Blood Cancer Drug Meets Late-Stage Trial Goals

Reuters
·
Sep 03

Abbvie - Phase 3 Cervino Study Met Dual Primary Endpoints; Full Results to be Presented Sept 23-26

THOMSON REUTERS
·
Sep 03